Abbvie Inc
SIX:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbvie Inc
SIX:ABBV
|
US |
|
Allianz SE
SIX:ALV
|
DE |
|
I
|
InnoTec TSS AG
XMUN:TSS
|
DE |
|
T
|
TTM Technologies Inc
DUS:TT1
|
US |
|
C
|
CCL Industries Inc
F:1C9
|
CA |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
M
|
MacroGenics Inc
F:M55
|
US |
|
C
|
Coeur Mining Inc
XMUN:CDM1
|
US |
|
T
|
Travelers Companies Inc
F:PA9
|
US |
|
Vertex Resource Group Ltd
F:4X8
|
CA |
|
K
|
KGHM Polska Miedz SA
XMUN:KGHA
|
PL |
|
Rush Enterprises Inc
F:RUN
|
US |
|
Reckitt Benckiser Group PLC
F:3RB
|
UK |
|
Unilever Indonesia Tbk PT
F:UTG
|
ID |
|
C
|
Cloudflare Inc
DUS:8CF
|
US |
|
K
|
Krones AG
DUS:KRN
|
DE |
|
Logan Energy Corp
F:R76
|
CA |
|
C
|
Coeur Mining Inc
F:CDM1
|
US |
|
Greenyard NV
F:2P1
|
BE |
|
W
|
Willow Biosciences Inc
OTC:CANSF
|
CA |
|
K
|
Keywords Studios PLC
F:KS3
|
IE |
|
B
|
Bayerische Motoren Werke AG
F:BMWB
|
DE |
|
A
|
Air China Ltd
XMUN:AD2
|
CN |
Bankruptcy Probability
Abbvie Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Abbvie Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
310.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
136.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Abbvie Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Abbvie Inc has total debt of 61.4B USD. This includes both short-term (2.5B USD) and long-term (58.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
